n-(3-(aminomethyl)benzyl)acetamidine has been researched along with mitoquinone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bloomfield, PS; Chapple, KJ; Davies, AL; Desai, RA; Diem, R; Fairless, R; Kasti, M; Linington, C; McIntosh, PR; Murphy, MP; Smith, KJ | 1 |
1 trial(s) available for n-(3-(aminomethyl)benzyl)acetamidine and mitoquinone
Article | Year |
---|---|
Neurological deficits caused by tissue hypoxia in neuroinflammatory disease.
Topics: Amidines; Animals; Benzylamines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Micronutrients; Organophosphorus Compounds; Oxygen; Rats; Recovery of Function; Severity of Illness Index; Single-Blind Method; Spinal Cord Diseases; Ubiquinone | 2013 |